Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Nov 10, 2022 1:24pm
163 Views
Post# 35089058

RE:RE:RE:RE:RE:How the heck….

RE:RE:RE:RE:RE:How the heck….MM - perhaps they had to wait until all conditions were right.  We only know what they disclosed about the Baxter change (US$2.5 mill invested) - we don't know what other changes might have been made to the (redacted) deal.  Why disclose changes to elements that are secret anyway?  You'd have to reveal the original secret first for the change to be understandable.  Could it be that part of it is helping with recruitment in some way from a large strategic partner intimately connected to the hospital sector?  One that is building their marketing force to attack the market "the day after FDA approval"?  Would they build a marketing fleet now ready for deployment if they weren't very certain of approval?

Perhaps with us now approaching the 11th day of the 11th month they are launching the D (deadline) day attack with a view to 100% success in capturing the big (PSU) prize.  I'd throw everything I possibly could at it and I'm sure they are doing exactly that.
<< Previous
Bullboard Posts
Next >>